Our mission is to deliver the highest quality comprehensive healthcare model to our patients.
The Center for Comprehensive Care and Diagnosis of Inherited Blood Disorders channels large subcontract grants into disease-specific care networks, with the biggest recent award going to the Sickle Cell Disease Foundation of California for the sickle cell treatment demonstration program. Its grantmaking is built around clinical service delivery and coordination for inherited blood disorders, especially sickle cell disease and hemophilia, rather than broad charitable support. Recent awards also show sustained backing for university and hospital partners that deliver treatment, surveillance, and network development across California and nearby states. The center’s recent grants include multiple payments to The Regents of the University of California at UCSF, UCSD, Davis, and UCLA for sickle cell treatment demonstration work and public health networking, alongside support for Loma Linda University Health Care, Kern Medical Center Foundation, Valley Children’s Hospital of Central California, and Children’s Hospital Los Angeles. This pattern points to a funder that works through established clinical and public health institutions to support patient services, regional coordination, and specialized care for adults and children living with blood disorders.
Sickle cell disease is the clearest throughline in the center’s grantmaking. It gave $2,598,002 to The Regents of the University of California (UCSF) for the sickle cell treatment demonstration program, and $2,408,220 to the same grantee for California Department of Public Health networking work tied to the Network for California Sickle Cell Care. The center also supports hemophilia infrastructure. It awarded $260,618 to Valley Children’s Hospital of Central California for the HRSA hemophilia regional comprehensive care program and $193,842 to Hemostasis and Thrombosis Center of NV for the same program. Public health surveillance appears in its portfolio as well: Valley Children’s Hospital received $152,444 for CDC/ATHN grant public health surveillance, and The Regents of the University of California (Davis) received $132,316 for that purpose. Adult-focused sickle cell services are another visible thread, including a $2,000,000 subcontract to the Sickle Cell Disease Foundation of California for Queens Care LA County adults living with sickle cell disease.
$4.8M
$85M
$33.6M
$19.3M
Most grants fall between $57K and $170K, with a median of $96K.
25th Percentile
$57K
Median
$96K
75th Percentile
$170K
DIANE J NUGENT MD
Sign up for a free Kindora account to access AI-generated insights into this funder's giving patterns, decision-makers, and fit signals.
Get Started FreeFree Kindora accounts unlock side-by-side comparisons with foundations that share this funder's focus areas and giving profile.
Get Started FreeSign up free to see how well your nonprofit fits this funder, get an AI-generated pitch, and unlock similar foundations.
Typical grants cluster in the mid-five-figure to low-six-figure range, with p25 at $56,734, median at $95,892, and p75 at $170,388. The recent grant list shows recurring funding relationships rather than one-off awards: The Regents of the University of California appears across multiple campuses and years, and the Sickle Cell Disease Foundation of California appears in 2023, 2024, and 2025. The foundation’s grants are structured as subcontracts tied to named programs and public agency funding streams. The active scholarship program is listed as accepting unsolicited applications; the broader grants program page does not show an application method.
Grantmaking is regional and concentrated in the western United States. California recipients dominate the portfolio, with 65% of grants going to recipients in the foundation’s HQ state. Outside California, the recent-grants list includes Nevada and Arizona recipients. Within California, repeated recipient cities include San Francisco, San Diego, Davis, Los Angeles, Ontario, and Sacramento, showing a network that spans academic medical centers, children’s hospitals, and disease-specific foundations.
Its recent grants support sickle cell treatment demonstration programs, hemophilia regional comprehensive care, public health surveillance through CDC/ATHN, networking for California sickle cell care, and adult-focused sickle cell services in Los Angeles County. The taxonomy also includes thalassemia, platelet disorders, thrombosis and clotting disorders, and women’s and rare bleeding disorders.
The grant-size distribution centers on mid-sized awards: p25 is $56,734, median is $95,892, and p75 is $170,388. Recent awards also include larger subcontract grants above $1 million for sickle cell demonstration and network work.
Yes. The Regents of the University of California appears repeatedly across UCSF, UCSD, Davis, and UCLA in 2023, 2024, and 2025. The Sickle Cell Disease Foundation of California also appears in multiple years, including support for both the sickle cell treatment demonstration program and adults living with sickle cell disease.
No. California receives most grants, but recent awards also went to organizations in Nevada and Arizona. The recipient country distribution is entirely U.S.-based, with 81 grants all in the United States.
Yes. The CIBD Scholarship Program is listed as a scholarship application program for California with a grant size of $500. The provided content says it accepts unsolicited applications.
2026
Source: IRS Form 990-PF, fiscal year 2026.
Most recent grants reported to the IRS.
| Recipient | Location | Amount | Year | Purpose |
|---|---|---|---|---|
| SICKLE CELL DISEASE FOUNDATION OF CALIFORNIA | ONTARIO, CA | $1,665,421 | 2026 | SUBCONTRACT HRSA & CDPH GRANTS SICKLE CELL TREATMENT DEMONSTRATION PROGRAM |
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (DAVIS) | SACRAMENTO, CA | $515,135 | 2026 | SUBCONTRACT HRSA & CDPH GRANTS SICKLE CELL TREATMENT DEMONSTRATION PROGRAM |
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (UCSF) | SAN FRANCISCO, CA | $439,866 | 2026 | SUBCONTRACT HRSA & CDPH GRANTS SICKLE CELL TREATMENT DEMONSTRATION PROGRAM |
| UCSF BENIOFF CHILDREN'S HOSPITALS FOUNDATION | OAKLAND, CA | $350,918 | 2026 | SUBCONTRACT HRSA GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM |
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (UCSD) | SAN DIEGO, CA | $228,544 | 2026 | SUBCONTRACT HRSA & CDPH GRANTS SICKLE CELL TREATMENT DEMONSTRATION PROGRAM |
| LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL | TORRANCE, CA | $170,895 | 2026 | SUBCONTRACT CDPH GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM |
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (UCLA) | LOS ANGELES, CA | $160,820 | 2026 | SUBCONTRACT CDPH GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM |
| ARROWHEAD REGIONAL MEDICAL CENTER | COLTON, CA | $155,377 | 2026 | SUBCONTRACT CDPH GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM |
| HEMOSTASIS AND THROMBOSIS CENTER OF NV | LAS VEGAS, NV | $115,554 | 2026 | SUBCONTRACT HRSA GRANT HEMOPHILIA REGIONAL COMPREHENSIVE CARE PROGRAM |
| KERN MEDICAL CENTER FOUNDATION | BAKERSFIELD, CA | $113,701 | 2026 | SUBCONTRACT CDPH GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM |
| VALLEY CHILDREN'S HOSPITAL OF CENTRAL CALIFORNIA | MADREA, CA | $110,594 | 2026 | SUBCONTRACT HRSA GRANT HEMOPHILIA REGIONAL COMPREHENSIVE CARE PROGRAM |
| LOMA LINDA UNIVERSITY HEALTH CARE | LOMA LINDA, CA | $109,061 | 2026 | SUBCONTRACT CDPH GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM |
| LUCILE PACKARD CHILDREN'S HOSPITAL AT STANFORD | PALO ALTO, CA | $108,368 | 2026 | SUBCONTRACT HRSA GRANT HEMOPHILIA REGIONAL COMPREHENSIVE CARE PROGRAM |
| SEATTLE CHILDREN'S HOSPITAL | SEATTLE, WA | $88,076 | 2026 | SUBCONTRACT HRSA GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM |
| CHILDREN'S HOSPITAL LOS ANGELES | LOS ANGELES, CA | $84,693 | 2026 | SUBCONTRACT HRSA GRANT HEMOPHILIA REGIONAL COMPREHENSIVE CARE PROGRAM |
| LOS ANGELES ORTHOPAEDIC HOSPITAL | LOS ANGELES, CA | $61,111 | 2026 | SUBCONTRACT HRSA GRANT HEMOPHILIA REGIONAL COMPREHENSIVE CARE PROGRAM |
| RADY CHILDREN'S HOSPITAL - SAN DIEGO | SAN DIEGO, CA | $60,640 | 2026 | SUBCONTRACT CDC/ATHN GRANT PUBLIC HEALTH SURVEILLANCE |
| PHOENIX CHILDREN'S HOSPITAL | PHOENIX, AZ | $57,597 | 2026 | SUBCONTRACT HRSA GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM |
| UNIVERSITY OF COLORADO | AURORA, CO | $54,910 | 2026 | SUBCONTRACT HRSA GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM |
| IHC HEALTH SERVICES INC | SALT LAKE CITY, UT | $46,827 | 2026 | SUBCONTRACT HRSA GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM |
| THE UNIVERSITY OF ARIZONA | TUCSON, AZ | $36,419 | 2026 | SUBCONTRACT HRSA GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM |
| KAPI'OLANI MEDICAL CENTER FOR WOMEN AND CHILDREN | HONOLULU, HI | $30,966 | 2026 | SUBCONTRACT HRSA GRANT HEMOPHILIA REGIONAL COMPREHENSIVE CARE PROGRAM |
| OREGON HEALTH AND SCIENCE UNIVERSITY | PORTLAND, OR | $28,474 | 2026 | SUBCONTRACT HRSA GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM |
| JOHN HOPKINS UNIVERSITY | BALTIMORE, MD | $5,000 | 2026 | SUBCONTRACT HRSA GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM |
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (UCSF) | SAN FRANCISCO, CA | $829,478 | 2025 | SUBCONTRACT HRSA & CDPH GRANTS SICKLE CELL TREATMENT DEMONSTRATION PROGRAM |
| SICKLE CELL DISEASE FOUNDATION OF CALIFORNIA | ONTARIO, CA | $515,362 | 2025 | SUBCONTRACT HRSA & CDPH GRANTS SICKLE CELL TREATMENT DEMONSTRATION PROGRAM |
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (DAVIS) | SACRAMENTO, CA | $422,685 | 2025 | SUBCONTRACT HRSA & CDPH GRANTS SICKLE CELL TREATMENT DEMONSTRATION PROGRAM |
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (UCSD) | SAN DIEGO, CA | $229,139 | 2025 | SUBCONTRACT HRSA & CDPH GRANTS SICKLE CELL TREATMENT DEMONSTRATION PROGRAM |
| UCSF BENIOFF CHILDREN'S HOSPITALS FOUNDATION | OAKLAND, CA | $192,143 | 2025 | SUBCONTRACT HRSA GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM |
| ARROWHEAD REGIONAL MEDICAL CENTER | COLTON, CA | $146,456 | 2025 | SUBCONTRACT CDPH GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM |
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (UCLA) | LOS ANGELES, CA | $134,163 | 2025 | SUBCONTRACT CDPH GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM |
| THE UNIVERSITY OF ARIZONA | TUCSON, AZ | $134,163 | 2025 | SUBCONTRACT HRSA GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM |
| VALLEY CHILDREN'S HOSPITAL OF CENTRAL CALIFORNIA | MADREA, CA | $129,423 | 2025 | SUBCONTRACT HRSA GRANT HEMOPHILIA REGIONAL COMPREHENSIVE CARE PROGRAM |
| LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL | TORRANCE, CA | $118,578 | 2025 | SUBCONTRACT CDPH GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM |
| LOMA LINDA UNIVERSITY HEALTH CARE | LOMA LINDA, CA | $110,193 | 2025 | SUBCONTRACT CDPH GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM |
| HEMOSTASIS AND THROMBOSIS CENTER OF NV | LAS VEGAS, NV | $106,944 | 2025 | SUBCONTRACT HRSA GRANT HEMOPHILIA REGIONAL COMPREHENSIVE CARE PROGRAM |
| KERN MEDICAL CENTER FOUNDATION | BAKERSFIELD, CA | $100,000 | 2025 | SUBCONTRACT CDPH GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM |
| CHILDREN'S HOSPITAL LOS ANGELES | LOS ANGELES, CA | $88,282 | 2025 | SUBCONTRACT HRSA GRANT HEMOPHILIA REGIONAL COMPREHENSIVE CARE PROGRAM |
| LUCILE PACKARD CHILDREN'S HOSPITAL AT STANFORD | PALO ALTO, CA | $83,906 | 2025 | SUBCONTRACT HRSA GRANT HEMOPHILIA REGIONAL COMPREHENSIVE CARE PROGRAM |
| PHOENIX CHILDREN'S HOSPITAL | PHOENIX, AZ | $70,838 | 2025 | SUBCONTRACT HRSA GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM |
| RADY CHILDREN'S HOSPITAL - SAN DIEGO | SAN DIEGO, CA | $58,207 | 2025 | SUBCONTRACT CDC/ATHN GRANT PUBLIC HEALTH SURVEILLANCE |
| LOS ANGELES ORTHOPAEDIC HOSPITAL | LOS ANGELES, CA | $53,922 | 2025 | SUBCONTRACT HRSA GRANT HEMOPHILIA REGIONAL COMPREHENSIVE CARE PROGRAM |
| IHC HEALTH SERVICES INC | SALT LAKE CITY, UT | $44,508 | 2025 | SUBCONTRACT HRSA GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM |
| KAPI'OLANI MEDICAL CENTER FOR WOMEN AND CHILDREN | HONOLULU, HI | $44,148 | 2025 | SUBCONTRACT HRSA GRANT HEMOPHILIA REGIONAL COMPREHENSIVE CARE PROGRAM |
| SEATTLE CHILDREN'S HOSPITAL | SEATTLE, WA | $38,968 | 2025 | SUBCONTRACT HRSA GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM |
| OREGON HEALTH AND SCIENCE UNIVERSITY | PORTLAND, OR | $36,049 | 2025 | SUBCONTRACT HRSA GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM |
| UNIVERSITY OF COLORADO | AURORA, CO | $28,719 | 2025 | SUBCONTRACT HRSA GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM |
| SICKLE CELL DISEASE FOUNDATION OF CALIFORNIA | ONTARIO, CA | $6,223,826In-kind (goods, not cash) | 2024 | SUBCONTRACT HRSA & CDPH GRANTS SICKLE CELL TREATMENT DEMONSTRATION PROGRAM |
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (UCSF) | SAN FRANCISCO, CA | $2,598,002In-kind (goods, not cash) | 2024 | SUBCONTRACT HRSA & CDPH GRANTS SICKLE CELL TREATMENT DEMONSTRATION PROGRAM |
| LOMA LINDA UNIVERSITY HEALTH CARE | LOMA LINDA, CA | $1,121,886In-kind (goods, not cash) | 2024 | SUBCONTRACT CDPH GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM |
SICKLE CELL DISEASE FOUNDATION OF CALIFORNIA
$1,665,421SUBCONTRACT HRSA & CDPH GRANTS SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (DAVIS)
$515,135SUBCONTRACT HRSA & CDPH GRANTS SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (UCSF)
$439,866SUBCONTRACT HRSA & CDPH GRANTS SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
SUBCONTRACT HRSA GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (UCSD)
$228,544SUBCONTRACT HRSA & CDPH GRANTS SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
SUBCONTRACT CDPH GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (UCLA)
$160,820SUBCONTRACT CDPH GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
ARROWHEAD REGIONAL MEDICAL CENTER
$155,377SUBCONTRACT CDPH GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
HEMOSTASIS AND THROMBOSIS CENTER OF NV
$115,554SUBCONTRACT HRSA GRANT HEMOPHILIA REGIONAL COMPREHENSIVE CARE PROGRAM
KERN MEDICAL CENTER FOUNDATION
$113,701SUBCONTRACT CDPH GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
SUBCONTRACT HRSA GRANT HEMOPHILIA REGIONAL COMPREHENSIVE CARE PROGRAM
LOMA LINDA UNIVERSITY HEALTH CARE
$109,061SUBCONTRACT CDPH GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
SUBCONTRACT HRSA GRANT HEMOPHILIA REGIONAL COMPREHENSIVE CARE PROGRAM
SUBCONTRACT HRSA GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
SUBCONTRACT HRSA GRANT HEMOPHILIA REGIONAL COMPREHENSIVE CARE PROGRAM
SUBCONTRACT HRSA GRANT HEMOPHILIA REGIONAL COMPREHENSIVE CARE PROGRAM
SUBCONTRACT CDC/ATHN GRANT PUBLIC HEALTH SURVEILLANCE
SUBCONTRACT HRSA GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
UNIVERSITY OF COLORADO
$54,910SUBCONTRACT HRSA GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
SUBCONTRACT HRSA GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
THE UNIVERSITY OF ARIZONA
$36,419SUBCONTRACT HRSA GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
KAPI'OLANI MEDICAL CENTER FOR WOMEN AND CHILDREN
$30,966SUBCONTRACT HRSA GRANT HEMOPHILIA REGIONAL COMPREHENSIVE CARE PROGRAM
SUBCONTRACT HRSA GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
SUBCONTRACT HRSA GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (UCSF)
$829,478SUBCONTRACT HRSA & CDPH GRANTS SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
SICKLE CELL DISEASE FOUNDATION OF CALIFORNIA
$515,362SUBCONTRACT HRSA & CDPH GRANTS SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (DAVIS)
$422,685SUBCONTRACT HRSA & CDPH GRANTS SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (UCSD)
$229,139SUBCONTRACT HRSA & CDPH GRANTS SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
SUBCONTRACT HRSA GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
ARROWHEAD REGIONAL MEDICAL CENTER
$146,456SUBCONTRACT CDPH GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (UCLA)
$134,163SUBCONTRACT CDPH GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
THE UNIVERSITY OF ARIZONA
$134,163SUBCONTRACT HRSA GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
SUBCONTRACT HRSA GRANT HEMOPHILIA REGIONAL COMPREHENSIVE CARE PROGRAM
SUBCONTRACT CDPH GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
LOMA LINDA UNIVERSITY HEALTH CARE
$110,193SUBCONTRACT CDPH GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
HEMOSTASIS AND THROMBOSIS CENTER OF NV
$106,944SUBCONTRACT HRSA GRANT HEMOPHILIA REGIONAL COMPREHENSIVE CARE PROGRAM
KERN MEDICAL CENTER FOUNDATION
$100,000SUBCONTRACT CDPH GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
SUBCONTRACT HRSA GRANT HEMOPHILIA REGIONAL COMPREHENSIVE CARE PROGRAM
SUBCONTRACT HRSA GRANT HEMOPHILIA REGIONAL COMPREHENSIVE CARE PROGRAM
SUBCONTRACT HRSA GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
SUBCONTRACT CDC/ATHN GRANT PUBLIC HEALTH SURVEILLANCE
SUBCONTRACT HRSA GRANT HEMOPHILIA REGIONAL COMPREHENSIVE CARE PROGRAM
SUBCONTRACT HRSA GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
KAPI'OLANI MEDICAL CENTER FOR WOMEN AND CHILDREN
$44,148SUBCONTRACT HRSA GRANT HEMOPHILIA REGIONAL COMPREHENSIVE CARE PROGRAM
SUBCONTRACT HRSA GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
OREGON HEALTH AND SCIENCE UNIVERSITY
$36,049SUBCONTRACT HRSA GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
UNIVERSITY OF COLORADO
$28,719SUBCONTRACT HRSA GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
SICKLE CELL DISEASE FOUNDATION OF CALIFORNIA
$6,223,826In-kind (goods, not cash)SUBCONTRACT HRSA & CDPH GRANTS SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (UCSF)
$2,598,002In-kind (goods, not cash)SUBCONTRACT HRSA & CDPH GRANTS SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
LOMA LINDA UNIVERSITY HEALTH CARE
$1,121,886In-kind (goods, not cash)SUBCONTRACT CDPH GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM